Omalizumab for COPD with allergies
Treatments studied
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial tests if omalizumab, an allergy medication, can help people with COPD who have allergies to common indoor triggers like cat, dog, mouse, cockroach, or dust mite. It aims to reduce flare-ups and improve breathing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 40 years old
- You have COPD and use two or more long-acting inhalers
- You have smoked at least 10 pack-years (for example, 1 pack a day for 10 years)
- Your COPD symptoms are moderate to severe, or you have had a flare-up in the past year
- You are allergic to one or more common indoor allergens and are exposed to that allergen at home
- Your lung function test shows a low ratio and percent predicted
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if omalizumab (a drug that blocks allergy reactions) can help people with multiple food allergies. You might qualify if you have severe allergies to at least two foods like peanut, tree nuts, egg, or milk.
This study tests if a drug called dupilumab, given as a shot under the skin, can reduce airway inflammation in people aged 40-85 with moderate-to-severe COPD who also have signs of a specific type of inflammation called Type 2. It may help if you have frequent flare-ups and are already using multiple inhalers.
This study tests if omalizumab (Xolair), an injectable medicine that blocks allergy antibodies, can help people with food allergies tolerate small amounts of their trigger foods. It's for people with high total IgE levels who were not eligible for a related study.
This trial tests combining a biologic drug (omalizumab) with allergy drops (sublingual immunotherapy) to see if they work better together for people with moderate asthma triggered by dust mites. It may help control your asthma symptoms better.
This trial tests if omalizumab (Xolair) can improve skin reactions in people with food allergies. It may help reduce allergic symptoms triggered by foods like peanut, egg, or milk.
This trial studies whether starting omalizumab before asthma flare-ups begin can reduce how often children get worsening asthma that needs strong steroid medicine. It is for children with persistent asthma who have signs of allergic/asthma triggers and recent flare-up history.
Hear when a new Chronic Obstructive Pulmonary Disease (COPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.